•
Sep 30, 2021

Pliant Therapeutics Q3 2021 Earnings Report

Total Revenue
$1.61M
Previous year: $4.81M
-66.6%
EPS
-$0.75
Previous year: -$0.47
+59.6%
Gross Profit
$1.21M
Previous year: $4.81M
-74.9%
Cash and Equivalents
$45.2M
Previous year: $55.2M
-18.1%
Free Cash Flow
-$23M
Previous year: -$16.1M
+42.7%
Total Assets
$234M
Previous year: $312M
-25.0%

Pliant Therapeutics

Pliant Therapeutics